Aspen Pharmacare to buy GSK’s drug brand for US$1.13 billion
Aspen Pharmacare will purchase the Arixtra and Fraxiparine blood clotting dug brands of GSK. (Image source: Maxwell Hamilton/Flickr)
South African generic drug maker Aspen Pharmacare will buy GlaxoSmithKline’s (GSK) blood-clotting thrombosis drug brands and its manufacturing factory for US$1.13bn